|
|
ACKNOWLEDGMENT
This
meeting is presented by World Events Forum, Inc.
World Events Forum, Inc. is a project management company
focusing on meeting and event planning, destination
management and association/society management services,
respectively. Our edge lies in the ability to package
innovative programming ideas and cost effective
strategies delivered through highly personalized
services.
The meeting is supported
in part by:
As one of the world's leading
pharmaceutical companies, AstraZeneca's business is focused on
turning good ideas into innovative, effective medicines that
make a real difference in important areas of healthcare.
We discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. We also focus on getting the best from every medicine we make by exploring all the ways it can be used or improved.
At AstraZeneca, innovation is about more than just research. We aim to stimulate continued creativity throughout our organisation by maintaining a culture in which our people feel valued, energised and rewarded for their ideas and contribution to our success - ideas which can make a difference in all aspects of our business. And we support and encourage our people in discovering their own potential, through excellent learning and development opportunities that are available to them throughout their careers.
With a global business comes a global responsibility for consistently high standards of behaviour worldwide. We aim to effectively manage that responsibility and help to find new ways of bringing benefit to society to ensure that AstraZeneca continues to be welcomed as a valued member of the global community.
We are committed to continued achievement in all of these areas to ensure a healthy future for our business so that we can continue to help improve the lives of, and add value for, all those who benefit from it.
P L A T I N U M S P O N S O R
S
LUNDBECK
www.lundbeck.com
H. Lundbeck A/S is an
international pharmaceutical company dedicated in
research and development to find new drugs for treatment
of CNS disorders including depression, schizophrenia,
Alzheimer's disease and Parkinson's disease. Research
has been the foundation of our activities for more than
50 years, and our mission is to improve the quality of
life for people suffering from psychiatric and
neurological disorders. In 2005, the company's revenue
was DKK 9.1 billion (approximately EUR 1.2 billion or
USD 1.5 billion). The number of employees is
approximately 5,000 globally.
Lundbeck launched EbixaŽ
(memantine) for the treatment of Alzheimer’s disease in
2002. Memantine is currently the second-most prescribed
pharmaceutical for the treatment of Alzheimer’s Disease
worldwide and in Europe.
FOREST RESEARCH
INSTITUTE
www.frx.com
Our Mission:
We
develop distinguishable pharmaceutical products that improve
the health and well-being of patients.
Our Values:
Integrity: We do the right things for the right
reasons
Creativity: We look for better ways to achieve our
goals
Flexibility: Changing the way we do things is always
an option
Collaboration: We foster collaboration with Forest
Laboratories, with our partners and with external
organizations
Accountability: Every employee is empowered to make
decisions and is responsible for his/her actions.
GOLD SPONSORS
www.merz.com
www.ds-pharma.co.jp/english/index.html
Dainippon Pharmaceutical and Sumitomo Pharmaceuticals merged on
October 1, 2005, to create Dainippon Sumitomo Pharma, a new
corporation committed to serving the social good through
research and development programs designed to empower people to
lead fuller, healthier lives.
Among the capabilities being deployed to create new value
for shareholders and customers alike are research and
development programs that excel in sophistication and
creativity, quality and production systems that ensure the
enduring trust of our customers, some of Japan’s most
developed sales and marketing resources, and an unmatched
ability to provide reliable data to medical decision-makers.
www.alzforum.org
The Alzheimer Research Forum, founded in 1996, is the web's
most dynamic scientific community dedicated to understanding
Alzheimer's disease and related disorders. Access to the web
site is free to all. Our editorial priorities are as diverse
as the needs of the research community. The web site reports
on the latest scientific findings, from basic research to
clinical trials; creates and maintains public databases of
essential research data and reagents, and produces
discussion forums to promote debate, speed the dissemination
of new ideas, and break down barriers across the numerous
disciplines that can contribute to the global effort to cure
Alzheimer's disease.
SILVER SPONSOR
www.rpeptide.com
Media Partner
Community Partner
.jpg)
top
|
